Lexicon Pharmaceuticals, Inc. (LXRX)

1.87 +0.03 (+1.63%) USD  |  NASDAQ  |  Apr 17, 16:00
1.86 -0.01 (-0.53%) Pre-Market: 08:30
More

Lexicon Pharmaceuticals SG&A Expense (Quarterly) : 8.757M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for LXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Viemed Healthcare, Inc. 34.52M
ANI Pharmaceuticals, Inc. 82.79M
Novavax, Inc. 34.12M
Kura Oncology, Inc. 39.14M
Liquidia Corp. 48.24M